- Home
- DXR vs JSPR Comparison
DXR vs JSPR Comparison
Compare DXR & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- JSPR
- Stock Information
- Founded
- DXR 1970
- JSPR 2018
- Country
- DXR United States
- JSPR United States
- Employees
- DXR N/A
- JSPR N/A
- Industry
- DXR Medical/Dental Instruments
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DXR Health Care
- JSPR Health Care
- Exchange
- DXR Nasdaq
- JSPR Nasdaq
- Market Cap
- DXR 46.9M
- JSPR 47.6M
- IPO Year
- DXR N/A
- JSPR N/A
- Fundamental
- Price
- DXR $11.20
- JSPR $2.64
- Analyst Decision
- DXR Strong Buy
- JSPR Buy
- Analyst Count
- DXR 1
- JSPR 12
- Target Price
- DXR $25.00
- JSPR $30.78
- AVG Volume (30 Days)
- DXR 10.4K
- JSPR 175.5K
- Earning Date
- DXR 01-01-0001
- JSPR 11-06-2025
- Dividend Yield
- DXR N/A
- JSPR N/A
- EPS Growth
- DXR 3.46
- JSPR N/A
- EPS
- DXR 0.36
- JSPR N/A
- Revenue
- DXR $66,306.00
- JSPR N/A
- Revenue This Year
- DXR N/A
- JSPR N/A
- Revenue Next Year
- DXR N/A
- JSPR N/A
- P/E Ratio
- DXR $30.67
- JSPR N/A
- Revenue Growth
- DXR N/A
- JSPR N/A
- 52 Week Low
- DXR $6.55
- JSPR $2.27
- 52 Week High
- DXR $11.48
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- DXR 57.09
- JSPR 34.62
- Support Level
- DXR $10.27
- JSPR $2.58
- Resistance Level
- DXR $11.48
- JSPR $2.87
- Average True Range (ATR)
- DXR 0.54
- JSPR 0.12
- MACD
- DXR -0.02
- JSPR 0.02
- Stochastic Oscillator
- DXR 81.08
- JSPR 8.51
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.